KANJIN THERAPEUTICS, INC.
1 known investors
Kanjin Therapeutics is a biotechnology startup developing treatments to restore kidney function and address chronic kidney diseases, using a strategy of targeting the liver. Founded as a scientific spinout from Okayama University, it operates across the US and Japan.
BiotechDigital HealthHealthtechMedical Devices